1
项与 Dengue 1 Live Virus Human Challenge 相关的临床试验A Phase 1, Open-Label Clinical Trial With Dengue-1-Virus Live Virus Human Challenge (DENV-1-LVHC) Assessment of Healthy U.S. Adults Previously Primed With Tetravalent Dengue Virus Purified Inactivated Vaccine (TDEN-PIV) and Boosted With Tetravalent Dengue Virus Live Attenuated Vaccine Formulation (TDEN LAV)
The purpose of this research study is to test the protection of volunteers previously vaccinated with Tetravalent Dengue Virus (TDEN) Purified Inactivated Vaccine (PIV) with alum and boosted with TDEN live attenuated vaccine (LAV) formulation against a weakened form of an experimental dengue virus challenge. The Investigators will also include people that have not received the study vaccine. The Investigators are collecting information about how the vaccine protects against a dengue virus challenge as well as adding to knowledge about the safety of the challenge.
100 项与 Dengue 1 Live Virus Human Challenge 相关的临床结果
100 项与 Dengue 1 Live Virus Human Challenge 相关的转化医学
100 项与 Dengue 1 Live Virus Human Challenge 相关的专利(医药)
100 项与 Dengue 1 Live Virus Human Challenge 相关的药物交易